← FDA Drug Approvals (Drugs@FDA)

CHOLESTYRAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AIPING PHARM INC · Approved 2022-01-21

Drug application

FDA Application #

ANDA214877

Application type

Abbreviated New Drug Application (Generic)

Brand name

CHOLESTYRAMINE

Generic name

Cholestyramine

Active ingredients

CHOLESTYRAMINE

Dosage form

POWDER

Route

ORAL

Marketing status

Discontinued

Sponsor

AIPING PHARM INC

First approval

2022-01-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown